Health care quality

Johnson & Johnson to Address Racial and Social Injustice Through Platform that Aims to Eliminate Health Inequities for People of Color

Retrieved on: 
Tuesday, November 17, 2020
Articles, Health, Determinants of health, Health care quality, Public health, Health equity, Medical sociology, Johnson & Johnson

"That's why Johnson & Johnson is focusing its efforts and committing $100 million to address racial and social injustice as the critical public health issue that it is.

Key Points: 
  • "That's why Johnson & Johnson is focusing its efforts and committing $100 million to address racial and social injustice as the critical public health issue that it is.
  • Johnson & Johnson is investing in culturally competent community care solutions that create healthier outcomes for Black people and other communities of color.
  • Johnson & Johnson is leveraging its global network to also address social, environmental, and economic determinants related to health inequities.
  • Although this announcement represents immediate action, Johnson & Johnson's commitment to address racial and social injustice is enduring.

The American Cancer Society and Pfizer Launch Community Grants Focused on Addressing Systemic Race-Related Barriers that Contribute to Disparities in care Among Black Men and Women with Cancer

Retrieved on: 
Tuesday, November 17, 2020
Oncology, Health, Cancer survivor, Cancer, Medical specialties, Medicine, Health care quality, Anna María Nápoles, Gynecologic cancer disparities in the United States

ATLANTA, Nov. 17, 2020 /PRNewswire/ --The American Cancer Society and Pfizer have approved grants totaling more than $3.7 million in 10 communities focused on reducing racial disparities in care and helping optimize cancer outcomes for Black men and women.

Key Points: 
  • ATLANTA, Nov. 17, 2020 /PRNewswire/ --The American Cancer Society and Pfizer have approved grants totaling more than $3.7 million in 10 communities focused on reducing racial disparities in care and helping optimize cancer outcomes for Black men and women.
  • The goal is to address systemic race-related barriers and disparities in the delivery of care that impact outcomes across all cancer types.
  • The grants, funded by Pfizer Global Medical Grants and overseen by the American Cancer Society, are part of the Addressing Racial Disparities in Cancer Care Competitive Grant Program, a three-year collaboration working to promote equity in factors that impact cancer outcomes for Black men and women.
  • The awardees will pursue a variety of efforts, from cancer screening to support in cancer survivorship, for Black men and women that could otherwise go unserved.

PhRMA Announces First-Ever, Industry-Wide Principles on Clinical Trial Diversity

Retrieved on: 
Tuesday, November 17, 2020
Health, Articles, Clinical research, Pharmaceutical industry, Health care quality, Clinical trial, Design of experiments, Pharmaceutical Research and Manufacturers of America, Health equity

WASHINGTON, Nov. 17, 2020 /PRNewswire/ --Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced first-ever, industry-wide principles on clinical trial diversity.

Key Points: 
  • WASHINGTON, Nov. 17, 2020 /PRNewswire/ --Today, the Pharmaceutical Research and Manufacturers of America (PhRMA) announced first-ever, industry-wide principles on clinical trial diversity.
  • The principles focus on four main areas: building trust and acknowledging the historic mistrust of clinical trials within Black and Brown communities, reducing barriers to clinical trial access, using real-world data to enhance information on diverse populations beyond product approval and enhancing information about diversity and inclusion in clinical trial participation.
  • "The industry's new clinical trial diversity principles are an important step toward greater health equity," said Stephen J. Ubl, president and chief executive officer of PhRMA.
  • Critical to health equity for these communities is clinical trial diversity that better reflects intended treatment populations for different medicines and therapeutics.

Palarum Announces US Veterans Affairs to Evaluate Use of 'Smart Patient Sock' to Reduce Patient Falls

Retrieved on: 
Monday, November 16, 2020
Articles, Medical terminology, Health care quality, Patient safety, Internet of things, Patient, Health, Science and technology

This project is intended to support on-going VA efforts to improve patient safety and enhance nursing staff efficiencies.

Key Points: 
  • This project is intended to support on-going VA efforts to improve patient safety and enhance nursing staff efficiencies.
  • The Palarum PUP (Patient is UP) Fall Prevention System utilizes a specially designed patient smart sock that incorporates patented eTextile and IOT technology that provides real-time monitoring of patient movement.
  • Combined with an enhanced wireless alert system, the PUP socks will immediately detects and notifies the closest staff that a safety event has occurred from a high-risk patient.
  • Falls are particularly important because they are a major cause of preventable injury and disability around the world that disproportionally impacts older adults.

AmerisourceBergen Foundation Supports 20+ Organizations to Increase Access to Prescription Drug Resources and Abuse Prevention Education

Retrieved on: 
Monday, November 16, 2020
General Health, Foundation, Health, Philanthropy, Health sciences, Health, Pharmaceuticals policy, Pharmacy, Health care quality, AmerisourceBergen, Prescription drug, Pharmacovigilance, Opioid epidemic in the United States

At the AmerisourceBergen Foundation, we believe its our responsibility to expand access to quality healthcare and resources that support prescription drug safety in communities of need, said Gina Clark, President of the AmerisourceBergen Foundation.

Key Points: 
  • At the AmerisourceBergen Foundation, we believe its our responsibility to expand access to quality healthcare and resources that support prescription drug safety in communities of need, said Gina Clark, President of the AmerisourceBergen Foundation.
  • Several grants were given to organizations focused on providing diverse communities with targeted and culturally responsive opioid misuse prevention education and support programs.
  • For more information about the AmerisourceBergen Foundation and its approach enhance prescription drug safety, please visit www.amerisourcebergenfoundation.org .
  • Through strategic partnerships and community collaboration, the Foundation works to expand access to quality healthcare and provide resources to ensure prescription drug safety.

Applications Open For ERACE Research Award to Support Cancer Health Disparities Research

Retrieved on: 
Monday, November 16, 2020
Articles, Health care quality, Determinants of health, Health equity, Medical sociology, Public health, Race and health, Health, Anna María Nápoles, Health Disparities Center

The ERACE Research Award will support promising cancer researchers with funding and access to the ERACEpopulation-based cancer registrybased on race and ethnicity.

Key Points: 
  • The ERACE Research Award will support promising cancer researchers with funding and access to the ERACEpopulation-based cancer registrybased on race and ethnicity.
  • The award aims to examine potential differences in treatment patterns, outcomes, clinical practice, genomics, safety, and other cancer-related measures among populations with existing disparities, particularly those that exist among underrepresented groups, which could inform strategies to eliminate racial health disparities.
  • "We see tremendous opportunity for longer-term, sustainable impact by supporting researchers in conducting disparities research."
  • Research proposals should fuel innovative research addressing mitigation of health inequities among minority populations facing cancer.

Aziyo Biologics Awarded Breakthrough Technology Contract with Premier Inc.

Retrieved on: 
Thursday, November 12, 2020
Health care quality

SILVER SPRING, Md., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Aziyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, has been awarded a group purchasing agreement with Premier Inc., for Premiers Technology Breakthroughs Program.

Key Points: 
  • SILVER SPRING, Md., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Aziyo), a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, has been awarded a group purchasing agreement with Premier Inc., for Premiers Technology Breakthroughs Program.
  • We are honored to be recognized by Premier as a Breakthrough Technology and are excited to make CanGaroo available to their members to address implantable electronic device complications, said Ron Lloyd, President and CEO.
  • This contract recognizes the innovative regenerative medicine technology we have developed to help physicians better manage and potentially avoid complications for patients undergoing these procedures.
  • Premier is a leading healthcare improvement company, uniting an alliance of approximately 4,100 U.S. hospitals and 200,000 other providers to transform healthcare.

From Technology to Fashion: McDermott Announces Inaugural "Rise" Members

Retrieved on: 
Thursday, November 12, 2020
Articles, Determinants of health, Health care quality, Discrimination, Hatred, McDermott Will & Emery, Health equity, Racism, Institutional racism

CHICAGO, Nov. 12, 2020 /PRNewswire/ -- International law firm McDermott Will & Emery is proud to announce that the first 10 McDermott Rise Members have been selected.

Key Points: 
  • CHICAGO, Nov. 12, 2020 /PRNewswire/ -- International law firm McDermott Will & Emery is proud to announce that the first 10 McDermott Rise Members have been selected.
  • "McDermott Rise Members will be supported by our team's passion, creativity and commitment to fighting systemic racism through the provision of world-class legal services."
  • The team strives to reduce racial health disparities by leveraging the power of technology, media and community to improve health outcomes for women.
  • The market for this technology is sizeable ($8.6 billion of serviceable available market) but plagued with inadequate, overpriced products.

Patient Experience Journal Releases Fall 2020 Issue: Volume 7, Issue 3

Retrieved on: 
Thursday, November 12, 2020
Health care quality, Patient advocacy, Patient experience, Patient, Articles

NASHVILLE, Tenn., Nov. 12, 2020 /PRNewswire-PRWeb/ --The Beryl Institute announces the publication of Volume 7, Issue 3 of Patient Experience Journal (PXJ), an international, open access, peer-reviewed journal focused on research and proven practices around understanding and improving patient experience.

Key Points: 
  • NASHVILLE, Tenn., Nov. 12, 2020 /PRNewswire-PRWeb/ --The Beryl Institute announces the publication of Volume 7, Issue 3 of Patient Experience Journal (PXJ), an international, open access, peer-reviewed journal focused on research and proven practices around understanding and improving patient experience.
  • "Volume 7, Issue 3 has the distinction of publishing at a critical time, one that could be deemed a moment in which scholarship suffers.
  • Learn more: https://pxjournal.org/cgi/viewcontent.cgi?article=1515&context=journal
    Patient Experience Journal (PXJ) is a peer-reviewed, open-access journal published in association with The Beryl Institute .
  • We define the patient experience as the sum of all interactions, shaped by an organization's culture, that influence patient perceptions across the continuum of care.

COVID-19, a New Administration, and a Changing Marketplace: What We Know - What We Don't Know - Industry Analysis by Loyale Healthcare

Retrieved on: 
Thursday, November 12, 2020
Health care quality

And it can be seen in the historic achievements of scientists, researchers and caregivers in the healthcare industry.

Key Points: 
  • And it can be seen in the historic achievements of scientists, researchers and caregivers in the healthcare industry.
  • The noteworthy events listed above are apropos of an era defined by noteworthy events, especially in healthcare.
  • Healthcare's operating performance through Q3 affirms the conviction of several notable healthcare industry executives cited in the analysis.
  • Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers.